SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-013426
Filing Date
2023-04-25
Accepted
2023-04-24 20:56:13
Documents
12
Period of Report
2023-04-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35434
  Complete submission text file 0001493152-23-013426.txt   208847

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE idxg-20230421.xsd EX-101.SCH 3230
3 XBRL LABEL FILE idxg-20230421_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE idxg-20230421_pre.xml EX-101.PRE 22791
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3584
Mailing Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 412-224-6100
INTERPACE BIOSCIENCES, INC. (Filer) CIK: 0001054102 (see all company filings)

IRS No.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24249 | Film No.: 23841385
SIC: 3841 Surgical & Medical Instruments & Apparatus
Industrial Applications and Services